Valuation: DiaSorin S.p.A.

Market Cap 3.68B 4.27B 3.46B 3.15B 5.92B 408B 6B 40.51B 15.88B 204B 16.02B 15.67B 680B P/E 2026 *
21.5x
P/E 2027 * 19x
Enterprise Value 4.39B 5.09B 4.12B 3.75B 7.05B 486B 7.15B 48.28B 18.92B 244B 19.09B 18.68B 810B EV / Sales 2026 *
3.56x
EV / Sales 2027 * 3.23x
Free-Float
37.17%
Yield 2026 *
1.75%
Yield 2027 * 1.83%
1 day+0.11%
1 week-2.33%
Current month+3.67%
1 month+7.47%
3 months+5.70%
6 months+11.29%
Current year+8.57%
1 week 73.3
Extreme 73.3
76.58
1 month 63
Extreme 63
76.58
Current year 52.34
Extreme 52.34
77.64
1 year 52.34
Extreme 52.34
92.32
3 years 52.34
Extreme 52.34
112.35
5 years 52.34
Extreme 52.34
208.8
10 years 49.98
Extreme 49.98
211.8
Manager TitleAgeSince
Chief Executive Officer 60 26/03/2007
Director of Finance/CFO - 01/01/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 28/04/2016
Director/Board Member 63 26/03/2007
Chairman 57 29/04/2022
Date Insider Type Main position Quantity % Market Cap.
28/01/26 Buy

Chief Executive Officer

7,500 0.0134%
08/01/26 Buy

Director

700 0.0013%
08/01/26 Buy

Director

1,000 0.0018%
Change 5-day change 1-year change 3-year change Capi.($)
+0.11%-2.33%-12.08%-16.50% 4.27B
+2.91%-3.61%+171.03%+353.39% 21.1B
-0.68%-0.95%-42.92%-20.79% 9.96B
+3.99%-0.02%+335.07%+26.73% 7.31B
-0.23%-0.25%+79.97%+52.95% 6.59B
+0.02%-7.16%-39.57% - 6.16B
+0.41%+6.54%-12.57%-8.42% 5.97B
+3.29%+4.13%+87.09%+113.62% 4.55B
-2.38%+1.36%-21.04%-34.21% 2.85B
-0.28%+3.16%-49.15%+186.12% 1.51B
Average +0.68%+1.29%+49.58%+72.54% 7.03B
Weighted average by Cap. +1.27%-0.51%+86.07%+130.61%

Financials

2026 *2027 *
Net sales 1.23B 1.43B 1.16B 1.05B 1.98B 137B 2.01B 13.58B 5.32B 68.49B 5.37B 5.25B 228B 1.31B 1.52B 1.23B 1.12B 2.1B 145B 2.13B 14.4B 5.64B 72.67B 5.7B 5.57B 242B
Net income 181M 209M 169M 154M 290M 20B 294M 1.99B 778M 10.02B 785M 768M 33.32B 205M 238M 193M 176M 330M 22.76B 335M 2.26B 886M 11.4B 894M 874M 37.93B
Net Debt 707M 818M 663M 604M 1.14B 78.25B 1.15B 7.77B 3.05B 39.21B 3.07B 3.01B 130B 541M 627M 508M 463M 870M 59.97B 882M 5.95B 2.33B 30.04B 2.35B 2.3B 99.94B
Logo DiaSorin S.p.A.
DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2025, the group had 9 production sites located in Italy, the United States (4), Canada, Germany, the United Kingdom and Chine. Net sales are distributed geographically as follows: Italy (15.2%), Europe (24.9%), North America (51.8%), and other (8.1%).
Employees
3,260
Date Price Change Volume
17/08/26 74.50 +0.11% 97,961
14/08/26 €74.42 -0.64% 96,150
13/08/26 €74.90 +1.16% 136,086
12/08/26 €74.04 -3.32% 337,939
11/08/26 €76.58 +0.39% 176,011
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
74.42EUR
Average target price
71.66EUR
Spread / Average Target
-3.70%

Quarterly revenue - Rate of surprise